Literature DB >> 11530184

Lack of effect of treatment with penciclovir or acyclovir on the establishment of latent HSV-1 in primary sensory neurons in culture.

R L Smith1, J Morroni, C L Wilcox.   

Abstract

Recent studies suggest reductions in establishment of herpes simplex virus, type 1 (HSV-1) latency using the nucleoside analog penciclovir compared with acyclovir in the murine model. These observations raise the possibility that the new analogs may have novel activities that directly interfere with the establishment of the latent infection, suggesting a mechanism other than simply blocking the productive infection. To determine if penciclovir has a direct action on the establishment of latency, we compared the effects of penciclovir versus acyclovir in an in vitro model of HSV-1 latency in rat dorsal root ganglia neurons in culture. In neurons in culture, both penciclovir and acyclovir were highly effective in blocking the productive infection. However, neither penciclovir nor acyclovir blocked establishment of latency as demonstrated by similar percentages of neurons expressing the latency-associated transcript (LAT). Following removal of the respective nucleoside analog, latency was maintained until reactivation was induced by nerve growth factor deprivation. Similar virus titers were recovered after induction of reactivation of latent infections, which were established in the presence of either penciclovir or acyclovir. These results indicate that neither penciclovir nor acyclovir treatment directly prevents the establishment of latent HSV-1 infections in primary sensory neurons in culture.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11530184     DOI: 10.1016/s0166-3542(01)00155-3

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  5 in total

1.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

2.  Feasibility of Enhancing Skin Permeability of Acyclovir through Sterile Topical Lyophilized Wafer on Self-Dissolving Microneedle-Treated Skin.

Authors:  Uzair Nagra; Kashif Barkat; Muhammad U Ashraf; Maryam Shabbir
Journal:  Dose Response       Date:  2022-05-16       Impact factor: 2.623

3.  9-[4-Hydr-oxy-3-(hydroxy-meth-yl)but-yl]guanine monohydrate.

Authors:  Huang Tang; Feng-Jie Cheng; Nan Li; Yan-Cheng Liu; Zhen-Feng Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-28

4.  IFN-α-driven CCL2 production recruits inflammatory monocytes to infection site in mice.

Authors:  C D Conrady; M Zheng; N A Mandal; N van Rooijen; D J J Carr
Journal:  Mucosal Immunol       Date:  2012-06-13       Impact factor: 7.313

5.  Enhancement of transdermal penetration and bioavailability of poorly soluble acyclovir using solid lipid nanoparticles incorporated in gel cream.

Authors:  P S Gide; S K Gidwani; K U Kothule
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.